Quick fix: Bone fixation device utilizing high-strength, biocompatible polycarbonate helps speed patient recovery

Anaheim, Calif., February 11, 2014 — Medical device manufacturers are developing products that are less invasive, contribute to faster medical procedures and help speed patient recovery. To accomplish this, they are increasingly utilizing advanced, biocompatible thermoplastics in their medical devices.

The Super Staple™ Classic, for example, provides a superior and instantaneous bone compression force designed to improve bone healing, and reduce complications and healthcare costs, according to original equipment manufacturer (OEM) Metric Medical Devices, Inc. The bone fixation implant is pre-loaded into an easy-to-use delivery instrument.

After conducting material property evaluations for this medical device, Metric selected Makrolon® Rx2530 polycarbonate because of its high strength, temperature stability, clarity and biocompatibility.

“The performance of Makrolon Rx2530 has been excellent,” said Dan Wadsworth, vice president, Research and Development, Metric. “The Bayer MaterialScience team was remarkably responsive during the material selection and design phase.”

For optimum convenience and cost savings, the Super Staple™ Classic is offered as a sterile, disposable, complete procedure kit. Makrolon Rx2530 polycarbonate is injection molded to form the housing of the device, which is roughly the size of a syringe.

In addition to assisting with material selection, Bayer also conducted testing to demonstrate the material’s compliance with ISO-10993 and U.S. Federal Drug Administration biocompatibility guidelines.

“We worked closely with Metric, providing guidance related to selection of the Makrolon polycarbonate grade that best met the stringent requirements – including toughness and biocompatibility – for this application,” said Fred Woods, field market development, Polycarbonate, Bayer MaterialScience LLC.

“The Super Staple™ Classic demonstrates yet again how medical device OEMs and the healthcare market rely on our Makrolon polycarbonate and technical expertise to develop life-changing applications,” said Bruce Fine, market segment leader, Medical and Consumer Products – Polycarbonates, Bayer MaterialScience LLC.

Attendees at MD&M West Conference and Exposition, Feb. 10-13, in Anaheim, Calif., can visit Bayer’s booth (#2021) for more details about Bayer's material solutions for medical applications.

About Bayer MaterialScience LLC:

Bayer MaterialScience LLC is one of the leading producers of high-performance plastics in North America and is part of the global Bayer MaterialScience business with approximately 14,500 employees at 30 production sites around the world and 2012 sales of 11.5 billion euros. The company manufactures high-tech polymer materials and develops innovative solutions for products used in many areas of daily life. The main segments served are the automotive, electrical and electronics, construction, medical, and sports and leisure industries. Sustainability is central to Bayer MaterialScience LLC’s business and is based around the key areas of innovation, product stewardship, social responsibility and respect for the environment.

About Metric Medical Devices, Inc.:

Metric Medical Devices, Inc. is an extremity orthopedic medical device company. The company’s advanced technology internal bone fixation implants are designed to speed healing and reduce complications and healthcare costs. www.metricmd.com

For more information about Bayer MaterialScience's material technology for medical applications, call 1-800-662-2927, email medicalinfo@bayer.com or visit www.plastics.bayer.com/.

# # #

This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Editor’s Note: Follow news from Bayer MaterialScience on Twitter:
www.twitter.com/Bayer4Materials

Media Contact(s):

Name: John Skabardonis
Phone: 412-777-5200
Email: john.skabardonis@bayer.com